C1512772||anti-apoptotic
C0755726||PON2 protein
C0753137||Wnt
C0105770||β-catenin
C1327622||regulated
C1522449||radiotherapy
C1520113||Wnt signaling
C1512772||anti-apoptotic
C0006826||cancer
C0007587||cell death
C0178719||intracellular
C0086418||human
C0014442||enzyme
C1122373||Paraoxonase-2
C1122373||Paraoxonase-2
C1512772||anti-apoptotic
C0023418||leukemia
C0007634||cells
C1327622||regulating
C1327622||regulation
C0755726||PON2 protein
C1171362||expression
C1520113||Wnt
C0244988||GSK3β
C0105770||β-catenin
C1704259||pathway
C0023418||leukemia
C0007634||cells
C0936012||silico analysis
C0242481||promoter reporter studies
C0087111||treatment
C0007600||cell lines
C1517631||K562
C0007634||SCC-4
C0007634||PCI-13
C0753137||Wnt
C1749457||ligands
C0243077||inhibitors
C0936012||analysis
C1122373||Paraoxonase-2
C0105770||β-catenin
C1171362||expression
C0475358||tumor tissue
C0755726||Paraoxonase-2
C1171362||expression
C0087111||treatment
C0543467||surgery
C1522449||radio
C3665472||chemotherapy
C1327622||regulation
C1122373||Paraoxonase-2
C0753137||Wnt
C0244988||GSK3β
C0105770||β-catenin
C0243095||fundamental finding
C0753137||Wnt
C0244988||GSK3β
C0105770||β-catenin
C1327622||regulation
C1122373||Paraoxonase-2
C0006826||cancers
C0969625||multimethodological
C0027651||tumor
C0007587||cell death
C1122373||Paraoxonase-2
C0005516||biomarker
C0087111||therapy
C0220901||prognostic
C0041365||tumor marker